With a client-centric approach, Ex-ponent Investment Management invests with a focus on capital preservation and long-term growth. It builds close relationships with each of its clients and takes the time to understand their unique financial goals and risk tolerance. This enables them to construct diversified portfolios that are positioned to best meet their needs.

With the launch of its third fund, Exponent Investment Management has received commitments in excess of its EUR 1 billion target from a diversified group of leading investors. The funds have been earmarked for investments in a number of key sectors, including technology, healthcare and business services. The firm has already made investments in a number of Northern Ireland companies, including H&MV and Ethos Engineering as well as Chanelle Pharma and fintech company Fintrax. In addition, Exponent has invested in the global recycling and resource recovery solutions company Enva.

The Role of Financial Advisors in Wealth Growth

The firm has also recently brought its total spend in the Irish market to more than EUR 1 billion with the purchase of a major stake in Kingsbridge Healthcare Group, which operates seven hospitals and 11 clinics in Northern Ireland. The investment is backed by growth capital from US private equity firm 57 Stars and surgeons Suresh Tharma and Ashok Songra.

Discover whether Exponent, Inc is a buy, sell, or hold based on its grades, metrics, ratios and U.S. Securities and Exchange Commission reports using AAII’s expansive and robust screening tools. AAII members have access to a powerful data suite that helps them whittle down investment decisions and find stocks, ETFs or mutual funds that align with their goals and objectives.